Fertility preservation for women with malignant diseases: ethical aspects and risks

As cancer treatment becomes more and more effective, there is greater life expectancy for cancer patients. Because of this, depending upon the modality used in the treatment of cancer, the matter of infertility emerges before us as an issue of increasing significance. Sperm cryopreservation and embr...

Full description

Saved in:
Bibliographic Details
Published in:Gynecological endocrinology 2012-12, Vol.28 (12), p.937-940
Main Author: Küçük, Mert
Format: Article
Language:English
Subjects:
cancer
embryo cryopreservation
ethics
Female
Fertility preservation
Fertility Preservation - ethics
Fertility Preservation - legislation & jurisprudence
Fertility Preservation - methods
Fertility Preservation - psychology
Humans
Infertility, Female - complications
Infertility, Female - etiology
Infertility, Female - psychology
Infertility, Female - therapy
Informed Consent - ethics
Informed Consent - legislation & jurisprudence
Informed Consent - psychology
Informed Consent By Minors - ethics
Informed Consent By Minors - legislation & jurisprudence
Informed Consent By Minors - psychology
Male
Neoplasms - complications
Neoplasms - diagnosis
Neoplasms - psychology
Neoplasms - therapy
ovarian tissue cryopreservation
Prognosis
Therapies, Investigational - adverse effects
Therapies, Investigational - ethics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:As cancer treatment becomes more and more effective, there is greater life expectancy for cancer patients. Because of this, depending upon the modality used in the treatment of cancer, the matter of infertility emerges before us as an issue of increasing significance. Sperm cryopreservation and embryo cryopreservation are well-established methods of fertility preservation (FP). Besides these validated FP options, some FP techniques such as oocyte cryopreservation and ovarian tissue cryopreservation are as yet in the experimental stage. FP medicine has experienced some rapid developments in recent years. The advances in this branch of medicine, however, have also brought about new ethical, medical and legal issues. Some of these include problems with obtaining the informed consent of minors, issues that arise because of the experimental nature of some methods, financial problems and the accessibility of FP methods, and the question of what happens to gametes when a patient dies. This review seeks to discuss, in the light of current literature, some ethical and technical issues and risks related to the implementation of FP methods in women with cancer.
ISSN:0951-3590
1473-0766
DOI:10.3109/09513590.2012.683077